Bempedoic acid to lower cholesterol and inflammation in HIV
Treatments studied
Part of Heart & circulation, Hormones & metabolism, Immune system & allergy, Infections clinical trials.
This Phase 2 trial studies whether bempedoic acid can lower cholesterol and inflammation in people with HIV who are already on effective HIV medications. It may help reduce signs of artery inflammation that can contribute to heart and stroke risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a documented HIV infection and have been on the same HIV medicines continuously with an undetectable viral load for at least 12 weeks.
- Your CD4 count (a key immune cell measure) is at least 200.
- You are age 40 or older, and your LDL (“bad”) cholesterol is at least 50 mg/dL.
- You have either known cardiovascular disease (like prior heart attack or stroke) or at least one major risk factor (such as diabetes, smoking, high blood pressure, abnormal cholesterol, elevated inflammation marker hsCRP, or strong family history).
- Imaging shows enough “artery inflammation” at baseline (TBR must be above 1.6).
- If you can become pregnant: you must be post-menopausal/without periods for over 12 months, or use two reliable contraception methods (one hormonal and one barrier) and have a negative pregnancy test before starting; if you’re male, you must use contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This trial tests a new medicine called bempedoic acid compared to statins for people who have trouble sticking with statins. It looks at how well each medicine lowers 'bad' cholesterol and how well they are tolerated.
This study tests whether bempedoic acid, a new cholesterol-lowering medication, can help people with heart disease or very high cholesterol. You'd take it along with your current cholesterol medications to see if it further reduces your cholesterol levels and protects your heart.
This trial tests if bempedoic acid, a cholesterol-lowering drug, can reduce liver fat in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help those who have stable blood sugar and are not on certain other medications.
This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.
This study compares two new medicines—obicetrapib and bempedoic acid—to see which one better lowers cholesterol in people whose cholesterol remains high despite taking standard medications. If your cholesterol isn't controlled well enough with current drugs, this trial may help you access an experimental treatment.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.